Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Geisel School of Medicine, Department of Surgery, Hanover, New Hampshire, United States.
J Biomed Opt. 2018 Oct;23(10):1-19. doi: 10.1117/1.JBO.23.10.100901.
Breast conserving surgery (BCS) is an effective treatment for early-stage cancers as long as the margins of the resected tissue are free of disease according to consensus guidelines for patient management. However, 15% to 35% of patients undergo a second surgery since malignant cells are found close to or at the margins of the original resection specimen. This review highlights imaging approaches being investigated to reduce the rate of positive margins, and they are reviewed with the assumption that a new system would need high sensitivity near 95% and specificity near 85%. The problem appears to be twofold. The first is for complete, fast surface scanning for cellular, structural, and/or molecular features of cancer, in a lumpectomy volume, which is variable in size, but can be large, irregular, and amorphous. A second is for full, volumetric imaging of the specimen at high spatial resolution, to better guide internal radiologic decision-making about the spiculations and duct tracks, which may inform that surfaces are involved. These two demands are not easily solved by a single tool. Optical methods that scan large surfaces quickly are needed with cellular/molecular sensitivity to solve the first problem, but volumetric imaging with high spatial resolution for soft tissues is largely outside of the optical realm and requires x-ray, micro-CT, or magnetic resonance imaging if they can be achieved efficiently. In summary, it appears that a combination of systems into hybrid platforms may be the optimal solution for these two very different problems. This concept must be cost-effective, image specimens within minutes and be coupled to decision-making tools that help a surgeon without adding to the procedure. The potential for optical systems to be involved in this problem is emerging and clinical trials are underway in several of these technologies to see if they could reduce positive margin rates in BCS.
保乳手术(BCS)是治疗早期癌症的有效方法,只要切除组织的边缘没有疾病,符合患者管理的共识指南。然而,由于恶性细胞在原始切除标本的边缘附近或处发现,15%至 35%的患者需要进行第二次手术。本综述强调了正在研究的成像方法,以降低阳性边缘率,假设新系统需要接近 95%的高灵敏度和接近 85%的特异性来审查它们。这个问题似乎有两个方面。首先,在一个保乳术体积中,需要快速全面地扫描癌症的细胞、结构和/或分子特征,该体积的大小是可变的,但可能很大、不规则且无定形。其次,需要对标本进行全容积成像,以获得更高的空间分辨率,更好地指导内部放射学决策,了解刺状突起和导管轨迹,这可能表明表面涉及其中。这两个需求不容易通过单一工具来解决。需要快速扫描大表面的光学方法,具有细胞/分子灵敏度,以解决第一个问题,但对于软组织的高分辨率容积成像在很大程度上超出了光学领域的范围,如果可以有效地实现,则需要 X 射线、微 CT 或磁共振成像。综上所述,对于这两个非常不同的问题,组合系统成混合平台可能是最佳解决方案。该概念必须具有成本效益,在数分钟内对标本成像,并与有助于外科医生的决策工具相结合,而不会增加手术难度。光学系统参与该问题的潜力正在出现,并且这些技术中的几种技术正在进行临床试验,以观察它们是否可以降低 BCS 中的阳性边缘率。